In all these phases, the strength of AUC lies in its ability to provide a detailed molecular profile without requiring any labeling or modification of the molecules being studied. This non-invasive, detailed analysis ensures that drug developers have a clear understanding of their products at every stage, enabling the creation of safer and more effective drugs.

1. Research & Discovery:

Lead Compound Discovery:

  • Protein-ligand interactions: Understanding how potential drug molecules (ligands) bind to target proteins is crucial. AUC can determine binding constants, which give insights into the affinity of the interaction. High-affinity interactions might indicate a potential strong therapeutic effect.
  • Protein-protein interactions: Therapeutics like monoclonal antibodies might work by interacting with other proteins. AUC helps understand these interactions, their stoichiometries, and their strengths.
  • Nucleic acid interactions: For therapeutics like siRNA or antisense oligonucleotides, understanding their interaction with target RNA or DNA is vital. AUC can provide insights into these interactions.

Biophysical Characterization:

  • Oligomerization state: Many proteins can exist as monomers, dimers, or higher-order oligomers. Their therapeutic activity might depend on being in a particular state. AUC helps in identifying the prevalent state under different conditions.
  • Aggregation behavior: Aggregates can reduce efficacy and might be immunogenic, leading to adverse reactions. AUC can detect and quantify aggregates, ensuring the purity of drug candidates.

2. Preclinical Development

Formulation Studies:

  • Stability: AUC can monitor changes in molecular profiles over time, indicating protein unfolding or aggregation, which are signs of instability.
  • Solubility: Insoluble drug candidates can form aggregates. AUC can identify such aggregates, guiding researchers to optimize formulations for better solubility.
  • Forced Degradation: By changing temperature, pH, or other solution properties to a less-than-optimal physiological environment, the drug product is stressed and can be tested for stability and shelf life.

Comparability Studies

  • Profile similarity: If the manufacturing process changes, it's essential to ensure that the new product is identical to the original in terms of molecular characteristics. AUC can compare the two molecular profiles to ensure they match, especially concerning size distributions and interaction behaviors.

3. Clinical Trials

Drug-serum protein interactions

When a drug is administered, it might bind to serum proteins, affecting its availability. AUC can study these interactions, helping in understanding the drug's pharmacokinetics.

Therapeutic protein state in circulation

If the drug is a therapeutic protein or peptide, AUC can analyze patient samples to determine if the protein remains in its active state, or if it aggregates or degrades in the body.

4. Manufacturing

Quality Control

Batch-to-batch consistency: For each batch of a biopharmaceutical product, AUC can compare molecular profiles, ensuring the same quality and efficacy.

Absence of aggregates: Aggregates can be harmful and reduce drug efficacy. Our quality control step to ensure that the final product is free from aggregates.

© 2024 All Rights Reserved.